The claim layer: what the page may assert
The claim layer is about assertions, not the trial itself. Google's publisher content policies disallow ads on content that promotes harmful health claims or addresses a current significant health crisis in ways that contradict authoritative scientific consensus. Examples include anti-vaccination content, denial that AIDS or COVID-19 exists, and sexual orientation conversion therapy. For a diabetes clinical-trial page, this means no cure claims, no claims contradicting consensus, and no framing that presents a trial as proven therapy before evidence exists. Treat that as a copy constraint, not a medical benchmark; do not supply a clinical threshold. Sentences that read like health claims belong in claim review, not trial description.
The promise layer: enrollment guarantees and free offers
AdSense for Search violation guidance treats concrete, explicitly stated promises that cannot be fulfilled as egregious violations. Examples include free or cash offers, promises to hire, unreasonably cheap offers, promising loans, promising admission, and misrepresentation of identity. Trial-page copy drifts into this category fast: "guaranteed enrollment," "free treatment," or "everyone qualifies." These are promises the publisher cannot substantiate or control. The useful distinction is promotional promise versus informational description. "This page explains how trial listings are organized" describes. "Join and get free care" promises. Before launch, label each sentence as claim, promise, or description, and remove promises that depend on a sponsor's decision.
The identity layer: who runs the page and why
The misrepresentation rule reaches identity and purpose. Google's publisher content policies prohibit content that misrepresents or conceals information about the publisher, the content creator, the purpose of the content, or the content itself. They also prohibit falsely implying an association with, or endorsement by, another person, organization, product, or service. On a listing-style diabetes trial page, readers may assume the site is the sponsor, the trial site, or a referral partner. State who operates the page, that it is informational, and that a listing is not an endorsement. A sponsor link needs a relationship statement; do not use another organization's marks to suggest approval.
The prescription-drug boundary
A separate content rule marks a boundary. The prescription-drug policy disallows content that facilitates the online sale of prescription drugs, with online pharmacies as the example. An informational trial page is not automatically in that category, but pharmacy-adjacent copy can move it there: retail links, "buy now" phrasing, or a co-branded pharmacy offer. Keep commercial pharmacy language off the trial page. If a partner demands conversion-style copy, review it separately rather than adding it to trial information.
The targeting layer: health data and personalized ads
The targeting layer is separate from claims. Google's policies prohibit using audience data or cookie lists to select or personalize ads based on real or inferred sensitive information, including health records and data from sites or apps marketing to a specific condition group. This limits a diabetes-interest audience used for personalized ads, not health-adjacent publishing. Contextual placement is the alternative: page content sets ad context, not condition-based audience data. If personalized ads remain, the publisher must have rights to use audience data, add an interest-based ad notice (for example, the Ad Options icon), and follow self-regulatory codes such as the Digital Advertising Alliance's principles.
The disclosure layer: privacy policy and ad notices
Disclosure has two outputs. The in-ad notice belongs to personalized advertising; the privacy policy is broader. Google's publisher policies require the policy to disclose data collection, sharing, and use from Google products, including cookies, web beacons, IP addresses, or other identifiers. It must disclose that third parties may place and read cookies on the user's browser because of ads on the site. A permitted Google data-use disclosure is a prominent link to Google's data-use page. If the trial page has lead forms, the policy must match what it collects. Do not hide ad-tech disclosure in generic wording.
The revenue layer: restricted does not mean banned
Restricted content is not a publication ban. Publisher restrictions guidance says restricted pages can still carry AdSense code, but are likely to receive fewer ads than unrestricted content. Google Ads do not run on content tagged with a restriction, so some inventory may receive no bids. For a diabetes clinical-trial page, ask not only "Can we monetize?" but "What demand should we expect?" Traffic alone may not explain different fill and revenue versus general-health pages. Budget for lower demand and monitor after launch. Google reserves the right to revise its policies and says publishers must track published changes, so recheck live pages before major updates.
A pre-publication checklist
Use this pre-publication checklist:
- Health sentences avoid cure claims or claims contradicting authoritative scientific consensus.
- Copy avoids "guaranteed enrollment," "free treatment," and promises the site cannot fulfill.
- The page identifies the publisher, content creator, and content purpose.
- It states the site is neither sponsor nor trial site, and a listing is not an endorsement.
- Sponsor links avoid implied approval or false association.
- Page avoids pharmacy sales language or links facilitating prescription-drug sales.
- Personalized ads avoid condition-based lists and health data.
- Interest-based ad notice and DAA principles are in place when personalized ads run.
- Privacy policy discloses cookies, web beacons, IP addresses, and third-party cookies.
- A prominent Google data-use link matches actual data collection.
Where the evidence stops
This is a publishing-policy review, not a clinical-trial guide. No trial, medical, or regulatory source was retrieved, so no trial phases, eligibility thresholds, enrollment outcomes, sponsor names, or compensation figures appear. The scope is US-facing publishing under the cited Google rules; Google compliance is not federal or state trial-recruitment compliance. Policy text changes, and Google says publishers must track revisions. Revenue effects follow only the policies' wording. This is not legal or medical advice; no reviewer credential is claimed. Consult counsel and qualified professionals for legal or medical decisions.
研究の知恵